Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Clinical Drug Investigation|February 20, 2007
Treatment of Parkinson's disease: a survey of patients and neurologistsMatthias Fargel, Bernd Grobe, Eberhard Oesterle, et al.Future Oncology (London, England)|March 23, 2017
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic optionsSanjay Popat, Anders Mellemgaard, Martin Reck, et al.Schizophrenia Research. Cognition|October 11, 2021
The relationship between cognition and functioning in schizophrenia: A semi-systematic reviewSaifuddin Kharawala, Claudia Hastedt, Jana Podhorna, et al.Journal of Patient-Reported Outcomes|June 17, 2024
Psychometric evaluation of the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) scaleWilliam R Lenderking, Mark J Atkinson, Mary Kate Ladd, et al.Schizophrenia (Heidelberg, Germany)|October 17, 2025
Primary and secondary caregiver burden of cognitive impairment associated with schizophrenia: a qualitative study based on caregiver interviewsSébastien Tulliez, Alessandra Girardi, Matthew Ridley, et al.Clinical Colorectal Cancer|October 20, 2019
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 AnalysesHeinz-Josef Lenz, Guillem Argiles, Takayuki Yoshino, et al.JMIR Research Protocols|October 7, 2025
Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled TrialShaheen E Lakhan, Cornelia Dorner-Ciossek, Olya Besedina, et al.Pageof 1